InfanDx is a dynamic brand dedicated to improving child health through innovative diagnostic solutions. As a privately held company, they focus on developing and commercializing novel diagnostic technologies for prenatal testing, neonatal acute and critical care, and infant health. Their team of seasoned industry experts leads the way in identifying high-value diagnostic opportunities.

Headquartered in Cologne, Germany, InfanDx also has branch offices in Berlin, Germany, and Boston, MA, USA. They have a robust leadership team, including the Chief Executive Officer, Chief Operating Officer, and Chief Financial Officer, who are supported by a talented group of experts in their respective disciplines. With a strong commitment to scientific and clinical excellence, InfanDx has a distinguished Scientific Advisory Board comprised of renowned experts in neonatology, metabolomics, and biostatistics.

They collaborate with leading institutions and clinical partners to conduct research and develop cutting-edge biomarkers for various conditions. Driven by their mission to improve child health, InfanDx is at the forefront of precision medicine, utilizing advanced technologies and data-driven approaches to provide accurate and timely diagnoses. Experience the future of pediatric diagnostics with InfanDx